CNS Pharmaceuticals Inc. (CNSP) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for CNS Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$4.51
−11.22% today
Market cap
$7M
Overall quality
57/100
Kronos AI 30-day
−0.5%
4 of 8 simulated paths end higher
CNS Pharmaceuticals Inc. (CNSP) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $7M. It trades at $4.51, down 11.22% today. Its overall quality score is 57 out of 100, ranked against the whole US market. Kronos AI's 30-day forecast is −0.5% (4 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $5.05 (−0.5%) |
| Likely range | −4.5% … +3.8% |
| As of | 2026-10-27 |
4 of 8 simulated paths end higher.
Quality scores
| Profitability | 37 |
| Solvency | 93 |
| Growth | 40 |
| Overall | 57 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.